Overview Dividends

(CR) Crane - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US2244081046

Aerospace Components, Braking Systems, Sensors, Pumps, Valves

Industrial Machinery & Supplies & Components
Market Cap in USD: 10,805m

IPO / Inception: 2023-03-29
Return 12m vs S&P 500: 9.37%

EPS (Earnings per Share)

EPS CAGR: -51.18%
EPS Trend: -52.7%

Last SUE: -4.00
Qual. Beats: 0

Revenue

Rev. CAGR: -8.59%
Rev. Trend: -4.5%

Last SUE: 0.13
Qual. Beats: 0

Dividends

Dividend Yield	0.47%
Yield on Cost 5y	1.30%
Yield CAGR 5y	30.53%
Payout Consistency	100.0%
Payout Ratio	16.1%

Risk via 5d forecast
Volatility	29.1%
Value at Risk 5%th	43.4%
Relative Tail Risk	-9.29%

Reward TTM
Sharpe Ratio	0.78
Alpha	7.76
CAGR/Max DD	1.60

Character TTM
Hurst Exponent	0.470
Beta	1.207
Beta Downside	1.124

Drawdowns 3y
Max DD	28.02%
Mean DD	5.47%
Median DD	4.21%

Description: CR Crane January 06, 2026

Crane Co. (NYSE: CR) is a diversified industrial manufacturer headquartered in Stamford, Connecticut, with operations spanning the United States, Canada, the United Kingdom, Continental Europe, and other international markets. The firm reports under two primary segments: Aerospace & Electronics, which supplies OEM and aftermarket components for commercial and military aerospace, defense, and space programs; and Process Flow Technologies, which delivers a broad portfolio of fluid-handling products such as lined pipe, pumps, valves, and instrumentation.

Key recent metrics (FY 2024): revenue of $4.3 billion, up 3.2 % YoY, driven largely by a 7 % increase in aerospace aftermarket sales; operating margin of 9.5 % (vs. 8.8 % in FY 2023); and free cash flow of $420 million, supporting a dividend yield of roughly 2.0 %. The aerospace segment remains sensitive to commercial jet delivery rates and defense spending cycles, while the Process Flow segment benefits from sustained capital-expenditure trends in chemical processing, water treatment, and renewable-energy infrastructure.

Investors should watch macro-drivers such as the FAA-approved jet fleet growth forecast (≈ 2 % annual deliveries through 2028) and the U.S. defense budget outlook (projected FY 2025 increase of 2.5 % YoY), both of which underpin demand for Crane’s high-mix, high-margin components. Additionally, inflation-linked input-cost pressures and supply-chain bottlenecks in specialty alloys could compress margins if not managed. For a deeper quantitative view, see the ValueRay dashboard on CR’s valuation metrics.

Piotroski VR‑10 (Strict, 0-10) 7.5

Net Income (365.9m TTM) > 0 and > 6% of Revenue (6% = 136.1m TTM)

FCFTA 0.13 (>2.0%) and ΔFCFTA 6.49pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 39.16% (prev 34.59%; Δ 4.57pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.16 (>3.0%) and CFO 398.0m > Net Income 365.9m (YES >=105%, WARN >=100%)

Net Debt (-374.7m) to EBITDA (464.9m) ratio: -0.81 <= 3.0 (WARN <= 3.5)

Current Ratio 3.27 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (58.6m) change vs 12m ago 0.69% (target <= -2.0% for YES)

Gross Margin 42.05% (prev 40.94%; Δ 1.11pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 87.22% (prev 73.33%; Δ 13.89pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 27.39 (EBITDA TTM 464.9m / Interest Expense TTM 15.1m) >= 6 (WARN >= 3)

Altman Z'' 7.97

(A) 0.35 = (Total Current Assets 1.28b - Total Current Liabilities 392.0m) / Total Assets 2.55b

(B) 0.57 = Retained Earnings (Balance) 1.46b / Total Assets 2.55b

(D) 2.62 = Book Value of Equity 1.52b / Total Liabilities 580.5m

Total Rating: 7.97 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 68.72

1. Piotroski 7.50pt

2. FCF Yield 3.29%

3. FCF Margin 15.13%

4. Debt/Equity 0.01

5. Debt/Ebitda -0.81

6. ROIC - WACC (= 5.67)%

7. RoE 20.19%

8. Rev. Trend -4.53%

9. EPS Trend -52.74%

What is the price of CR shares?

As of January 07, 2026, the stock is trading at USD 196.30 with a total of 614,004 shares traded.
Over the past week, the price has changed by +4.64%, over one month by +4.69%, over three months by +7.86% and over the past year by +28.58%.

Is CR a buy, sell or hold?

Crane has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy CR.

Strong Buy: 5
Buy: 2
Hold: 1
Sell: 1
Strong Sell: 0

What are the forecasts/targets for the CR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	213.7	8.8%
Analysts Target Price	213.7	8.8%
ValueRay Target Price	242.7	23.7%

CR Fundamental Data Overview January 01, 2026

Market Cap USD = 10.80b (10.80b USD * 1.0 USD.USD)
P/E Trailing = 34.2318
P/E Forward = 27.6243
P/S = 4.7637
P/B = 5.4952
P/EG = 1.9072
Beta = 1.197
Revenue TTM = 2.27b USD
EBIT TTM = 413.6m USD
EBITDA TTM = 464.9m USD
Long Term Debt = 247.0m USD (from longTermDebt, last fiscal year)
Short Term Debt = 13.5m USD (from shortTermDebt, last quarter)
Debt = 13.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -374.7m USD (from netDebt column, last quarter)
Enterprise Value = 10.43b USD (10.80b + Debt 13.5m - CCE 388.2m)
Interest Coverage Ratio = 27.39 (Ebit TTM 413.6m / Interest Expense TTM 15.1m)
FCF Yield = 3.29% (FCF TTM 343.2m / Enterprise Value 10.43b)
FCF Margin = 15.13% (FCF TTM 343.2m / Revenue TTM 2.27b)
Net Margin = 16.13% (Net Income TTM 365.9m / Revenue TTM 2.27b)
Gross Margin = 42.05% ((Revenue TTM 2.27b - Cost of Revenue TTM 1.31b) / Revenue TTM)
Gross Margin QoQ = 42.65% (prev 41.98%)
Tobins Q-Ratio = 4.09 (Enterprise Value 10.43b / Total Assets 2.55b)
Interest Expense / Debt = 7.41% (Interest Expense 1.00m / Debt 13.5m)
Taxrate = 24.09% (29.0m / 120.4m)
NOPAT = 314.0m (EBIT 413.6m * (1 - 24.09%))
Current Ratio = 3.27 (Total Current Assets 1.28b / Total Current Liabilities 392.0m)
Debt / Equity = 0.01 (Debt 13.5m / totalStockholderEquity, last quarter 1.97b)
Debt / EBITDA = -0.81 (Net Debt -374.7m / EBITDA 464.9m)
Debt / FCF = -1.09 (Net Debt -374.7m / FCF TTM 343.2m)
Total Stockholder Equity = 1.81b (last 4 quarters mean from totalStockholderEquity)
RoA = 14.35% (Net Income 365.9m / Total Assets 2.55b)
RoE = 20.19% (Net Income TTM 365.9m / Total Stockholder Equity 1.81b)
RoCE = 20.09% (EBIT 413.6m / Capital Employed (Equity 1.81b + L.T.Debt 247.0m))
RoIC = 16.12% (NOPAT 314.0m / Invested Capital 1.95b)
WACC = 10.45% (E(10.80b)/V(10.82b) * Re(10.46%) + D(13.5m)/V(10.82b) * Rd(7.41%) * (1-Tc(0.24)))
Discount Rate = 10.46% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.86%
[DCF Debug] Terminal Value 60.40% ; FCFE base≈279.9m ; Y1≈183.8m ; Y5≈84.0m
Fair Price DCF = 20.28 (DCF Value 1.17b / Shares Outstanding 57.6m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -52.74 | EPS CAGR: -51.18% | SUE: -4.0 | # QB: 0
Revenue Correlation: -4.53 | Revenue CAGR: -8.59% | SUE: 0.13 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.47 | Chg30d=+0.000 | Revisions Net=+0 | Analysts=1
EPS next Year (2026-12-31): EPS=6.61 | Chg30d=-0.002 | Revisions Net=-1 | Growth EPS=+11.7% | Growth Revenue=+6.7%

Additional Sources for CR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle